Extracellular vesicle biomarker signature analysis

Extracellular vesicle biomarker signature analysis refers to the process of detecting and characterizing specific biomarker patterns or "signatures" found on populations of extracellular vesicles (EVs) isolated from biological fluids such as blood, urine, or saliva[2][3][5]. This approach utilizes technologies such as multiplexed immunofluorescence, flow cytometry, microfluidics, and proteomics to profile surface proteins, nucleic acids, and other molecular cargo of EVs with the aim of enabling disease diagnosis, prognosis, or therapeutic monitoring[1][2][5][6][7]. Instead of being a single molecular entity like a receptor or enzyme, "Extracellular vesicle biomarker signature analysis" represents a class of **diagnostic techniques** whose target is the composite molecular signature present on EVs, which are themselves heterogeneous, membrane-bound particles secreted by nearly all cell types[2][3][5][7]. As such, it is not a therapeutic target and the entry appears to be conceptually or categorically incorrect in the context of target molecule or receptor databases. The meaningful targets in this context would be specific proteins, lipids, RNA, or other biomolecules present on or within EVs, or the EVs themselves as a class (e.g., "Extracellular vesicle" or "Exosome")[2][3][5][7].